Effects of benazepril on functional activity of endothelial progenitor cells from hypertension patients

References

• Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964–6
   PubMed Web of Science ®Google Scholar
• Shi Q, Rafii S, Hong-De Wu M, et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998;92:362–7
   PubMed Web of Science ®Google Scholar
• Iwakura A, Luedemann C, Shastry S, et al. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 2003;108:3115–21
   PubMed Web of Science ®Google Scholar
• Kawamoto A, Gwon H, Iwaguro H, et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001;103:634–7
   PubMed Web of Science ®Google Scholar
• Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001;7:430–6
   PubMed Web of Science ®Google Scholar
• Assmus B, Schächinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002;106:3009–17
   PubMed Web of Science ®Google Scholar
• Schmidt-Lucke C, Rössig L, Fichtlscherer S, et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005;111:2981–7
   PubMed Web of Science ®Google Scholar
• Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. New Engl J Med 2005;353:999–1007
   PubMed Web of Science ®Google Scholar
• Cacciatore F, Bruzzese G, Vitale DF, et al. Effects of ACE inhibition on circulating endothelial progenitor cells, vascular damage, and oxidative stress in hypertensive patients. Eur J Clin Pharmacol 2011;67:877–83
   PubMed Web of Science ®Google Scholar
• Ratajczak MZ, Zuba-Surma E, Kucia M, et al. The pleiotropic effects of the SDF-1–CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia 2006;20:1915–24
   PubMed Web of Science ®Google Scholar
• Walter DH, Haendeler J, Reinhold J, et al. Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res 2005;97:1142–51
   PubMed Web of Science ®Google Scholar
• Sbaa E, DeWever J, Martinive P, et al. Caveolin plays a central role in endothelial progenitor cell mobilization and homing in SDF-1-driven postischemic vasculogenesis. Circ Res 2006;98:1219–27
   PubMed Web of Science ®Google Scholar
• Nimura A, Muneta T, Koga H, et al. Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum. Arthritis Rheum 2008;58:501–10
   PubMed Web of Science ®Google Scholar
• Khakoo AY, Finkel T. Endothelial progenitor cells. Annu Rev Med 2005;56:79–101
   PubMed Web of Science ®Google Scholar
• Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. New Engl J Med 2003;348:593–600
   PubMed Web of Science ®Google Scholar
• Juonala M, Viikari JS, Rönnemaa T, et al. Elevated blood pressure in adolescent boys predicts endothelial dysfunction the cardiovascular risk in young finns study. Hypertension 2006;48:424–30
   PubMed Web of Science ®Google Scholar
• Clozel M, Kuhn H, Hefti F. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension 1990;16:532–40
   PubMed Web of Science ®Google Scholar
• Chen D, Dong Y, Yuan H, Chen AF. Endothelin 1 activation of endothelin A receptor/NADPH oxidase pathway and diminished antioxidants critically contribute to endothelial progenitor cell reduction and dysfunction in salt-sensitive hypertension. Hypertension 2012;59:1037–43
   PubMed Web of Science ®Google Scholar
• Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction testing and clinical relevance. Circulation 2007;115:1285–95
   PubMed Web of Science ®Google Scholar
• Sorrentino SA, Bahlmann FH, Besler C, et al. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus restoration by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone. Circulation 2007;116:163–73
   PubMed Web of Science ®Google Scholar
• António N, Fernandes R, Rodriguez-Losada N, et al. Stimulation of endothelial progenitor cells: a new putative effect of several cardiovascular drugs. Eur J Clin Pharmacol 2010;66:219–30
   PubMed Web of Science ®Google Scholar
• Oliveras A, Soler MJ, Martinez-Estrada OM, et al. Endothelial progenitor cells are reduced in refractory hypertension. J Hum Hypertens 2007;22:183–90
   PubMed Web of Science ®Google Scholar
• Bahlmann FH, de Groot K, Mueller O, et al. Stimulation of endothelial progenitor cells a new putative therapeutic effect of angiotensin ii receptor antagonists. Hypertension 2005;45:526–9
   PubMed Web of Science ®Google Scholar
• Dernbach E, Urbich C, Brandes RP, et al. Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood 2004;104:3591–7
   PubMed Web of Science ®Google Scholar
• Chen J, Chen S, Chen Y, et al. Circulating endothelial progenitor cells and cellular membrane microparticles in db/db diabetic mouse: possible implications in cerebral ischemic damage. Am J Physiol Endoc M 2011;301:E62–71
   PubMed Web of Science ®Google Scholar
• Huentelman MJ, Zubcevic J, Katovich MJ, Raizada MK. Cloning and characterization of a secreted form of angiotensin-converting enzyme 2. Regul Pept 2004;122:61–7
   PubMed Web of Science ®Google Scholar
• Werner N, Priller J, Laufs U, et al. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol 2002;22:1567–72
   PubMed Web of Science ®Google Scholar
• Silva PM. From endothelial dysfunction to vascular occlusion: role of the renin-angiotensin system. Rev Port Cardiol 2010;29:801–24
   PubMedGoogle Scholar
• Chen S, Huang C, Zhang W, et al. Bone marrow derived endothelial progenitor cells are reduced and dysfunctional in human renin and angiotensinogen double transgenic mice. Arterioscler Thromb Vasc Biol 2008;28:e76
   Web of Science ®Google Scholar
• Xu D, Davis BB, Wang Z, et al. A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARγ to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction. Int J Cardiol 2013;167:1298–304
   Google Scholar
• Yamaguchi J, Kusano KF, Masuo O, et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003;107:1322–8
   PubMed Web of Science ®Google Scholar